CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 58 enrolled
Drug / intervention
Rice Flour +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03157284
NCT03157284N/ACompleted
CompareCT.gov

Efficacy of Fermented Rice Flour for the Treatment of Atopic Dermatitis : Randomized, Double-Blind, Placebo-Controlled Trial

Heinz Italia SpA·interventional·Posted May 17, 2017·Updated Dec 18, 2019

In Brief

A clinical study evaluating Rice Flour and Placebo for Atopic Dermatitis. Completed, enrolled 58 participants across 1 site.

Detailed Summary

This Study Evaluate the efficacy of the subministration of fermented rice flour (7 g/day) on the clinical course of patients with moderate or severe Atopic Dermatitis, in terms of a reduction in the SCORAD score, during the study period and four weeks after the suspension of the treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtopic Dermatitis
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMay 17, 2017
Enrollment StartJan 23, 2017
Primary CompletionMay 24, 2019
Study CompletionMay 29, 2019
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 9.1 years ago

Interventions

Rice Flourdietary

For 12 weeks, a group of children will receive 7gr fermented rice flour according to a randomised, double-blind design.

Placebodietary

For 12 weeks a group of children will receive a 7gr of a placebo (maltodextrin), according to a randomised, double-blind design.